
|Slideshows|August 11, 2017
FDA Drug and Biologic Approvals for Neurology: 2017 Midyear Review
Author(s)Natalie Timoshin
Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Assessing Antisense Oligonucleotide Apazunersen in Pediatric Angelman Syndrome: The Aspire Study
2
Previewing Expected FDA Decisions in Neurology for 2026
3
NeurologyLive® Year in Review 2025: Top Interviews on the AI Takeover
4
NeuroVoices: David A. Hafler, MD, FANA, on Understanding MS as an Autoimmune and Neurodegenerative Disease
5

























